New medical trials have proven that HDIT/HCT can cause an induced sustained cutback of degenerating multiple sclerosis. This is an autoimmune ailment in which the immune system attacks the CNS (Central Nervous System). The treatment called HDIT/HCT entails using a high-dose immunosuppressive therapy which is then followed by transplantation of blood-forming stem cells.
Five years after receiving treatment with the high-dose immunosuppressive therapy and hematopoietic cell transplant, 69 percent of the participants in the trial survived without progression of disability, new brain lesions or relapse of multiple sclerosis symptoms. This trial which was called HALT-MS was sponsored by NIAID; National Institute of Allergy and Infectious Diseases. This is an organization that has affiliations with the National Institute of Health. The trial was conducted by ITN (Immune Tolerance Network) which is funded by the National Institute of Allergy and Infectious Diseases.
One of the most significant practitioners in the field of neurology is New Jersey-based Dr. Shiva Gopal Vasishta. The neurologist who is located in Voorhees has close affiliations with the Kennedy University Hospital. He has rich educational background having attended the Government Medical College Nagpur from where he attained his medical degree.
Dr. Shiva Gopal Vasishta also boasts of an outstanding wealth of experience. He has spent more than three decades studying and specializing in Neurology. Dr. Shiva Gopal Vasishta boasts to be among the 34 doctors in Kennedy University Hospital specializing in Neurology. Dr. Shiva Gopal Vasishta is also a member of the Eastern Neurodiagnostic Assoc Pc. Shiva has a license of operation issued in New Jersey. Dr. Vasishta is a participant in the Medicare program. Dr. Shiva also takes Medicare assignments; this translates to the fact that he accepts Medicare approved amount and clients do not get billed any amount above the Medicare coinsurance as well as deductible.